American Oncology Institute (AOI), a leading cancer hospital network in South Asia, successfully treated a 61-year-old ...

PT-112 monotherapy advances to phase 3 trial in metastatic castration-resistant prostate cancer after positive FDA end of ...

Announced the completion of FibroBiologics' proprietary master cell bank that will support upcoming clinical trials. Manufactured in accordance with FDA Good Manufacturing Practices (cGMP), the cell ...

Discoveries made at Harvard Medical School have improved the health and lives of countless people. Today, we continue our progress toward the treatments of tomorrow.

The complaint states the doctors’ negligence worsened her case of myasthenia gravis, or MG – an autoimmune disease that can cause muscle weakness and thymus cancer. “The decedent was never afforded ...

The presentation details a new method for creating a transplantable and scalable artificial thymus organoid intended to restore T-cell functionality, which is crucial for immune system health.

Founded in 2001, ThymUS brings together international researchers working on thymus and T-cell biology. The abstract entitled “A rapid and scalable thymus organoid development method for ...